A detailed history of Miller Howard Investments Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Miller Howard Investments Inc holds 1,068,251 shares of GILD stock, worth $96 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
1,068,251
Previous 704,047 51.73%
Holding current value
$96 Million
Previous $51.6 Million 42.12%
% of portfolio
2.44%
Previous 1.7%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$63.15 - $72.88 $23 Million - $26.5 Million
364,204 Added 51.73%
1,068,251 $73.3 Million
Q1 2024

Apr 12, 2024

SELL
$71.58 - $87.29 $815,367 - $994,320
-11,391 Reduced 1.59%
704,047 $51.6 Million
Q4 2023

Jan 26, 2024

SELL
$73.27 - $83.09 $376,534 - $426,999
-5,139 Reduced 0.71%
715,438 $58 Million
Q3 2023

Oct 18, 2023

SELL
$73.94 - $80.67 $254,353 - $277,504
-3,440 Reduced 0.48%
720,577 $54 Million
Q2 2023

Jul 21, 2023

SELL
$76.01 - $86.7 $1.82 Million - $2.08 Million
-23,943 Reduced 3.2%
724,017 $55.8 Million
Q1 2023

May 03, 2023

BUY
$77.31 - $88.08 $670,045 - $763,389
8,667 Added 1.17%
747,960 $62.1 Million
Q4 2022

Feb 02, 2023

BUY
$62.32 - $89.47 $4.32 Million - $6.2 Million
69,268 Added 10.34%
739,293 $63.5 Million
Q3 2022

Oct 27, 2022

SELL
$59.54 - $68.01 $8.93 Million - $10.2 Million
-149,954 Reduced 18.29%
670,025 $41.3 Million
Q2 2022

Jul 26, 2022

BUY
$57.72 - $65.01 $861,932 - $970,794
14,933 Added 1.85%
819,979 $50.7 Million
Q1 2022

Apr 21, 2022

SELL
$57.92 - $72.58 $3.18 Million - $3.99 Million
-54,927 Reduced 6.39%
805,046 $47.9 Million
Q4 2021

Feb 03, 2022

BUY
$64.88 - $73.64 $176,149 - $199,932
2,715 Added 0.32%
859,973 $62.4 Million
Q3 2021

Oct 21, 2021

BUY
$67.69 - $73.03 $15.1 Million - $16.3 Million
222,612 Added 35.08%
857,258 $59.9 Million
Q2 2021

Aug 04, 2021

BUY
$63.47 - $69.35 $111,262 - $121,570
1,753 Added 0.28%
634,646 $43.7 Million
Q1 2021

Apr 16, 2021

BUY
$60.0 - $68.46 $5.68 Million - $6.48 Million
94,592 Added 17.57%
632,893 $40.9 Million
Q4 2020

Jan 27, 2021

SELL
$56.65 - $64.55 $4.11 Million - $4.68 Million
-72,544 Reduced 11.88%
538,301 $31.4 Million
Q3 2020

Oct 30, 2020

SELL
$62.1 - $78.08 $2.72 Million - $3.42 Million
-43,762 Reduced 6.69%
610,845 $38.6 Million
Q2 2020

Jul 29, 2020

SELL
$72.34 - $84.0 $16.6 Million - $19.3 Million
-229,546 Reduced 25.96%
654,607 $50.4 Million
Q1 2020

May 05, 2020

SELL
$62.63 - $80.22 $28 Million - $35.9 Million
-447,134 Reduced 33.59%
884,153 $66.1 Million
Q4 2019

Feb 04, 2020

BUY
$61.62 - $67.78 $541,639 - $595,786
8,790 Added 0.66%
1,331,287 $86.5 Million
Q3 2019

Oct 17, 2019

SELL
$62.51 - $69.0 $3.74 Million - $4.12 Million
-59,767 Reduced 4.32%
1,322,497 $83.8 Million
Q2 2019

Jul 17, 2019

BUY
$61.87 - $69.38 $85.5 Million - $95.9 Million
1,382,264 New
1,382,264 $93.4 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Miller Howard Investments Inc Portfolio

Follow Miller Howard Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Howard Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Miller Howard Investments Inc with notifications on news.